Lapatinib and trastuzumab combination shrinks HER2-positive cancer

被引：0
|
作者：
Coles, Charlotte [1 ]
机构：
[1] Cambridge Univ Hosp NHS Trust, Cambridge, England
来源：
BRITISH JOURNAL OF HOSPITAL MEDICINE | 2016年 / 77卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：206 / 206
页数：1
相关论文
共 50 条
  • [21] Trastuzumab In HER2-Positive Metastatic Gastric Cancer
    Croxtall, Jamie D.
    McKeage, Kate
    DRUGS, 2010, 70 (17) : 2259 - 2267
  • [22] Trastuzumab (herceptin) and HER2-positive breast cancer
    Murray, S
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 174 (01) : 36 - 37
  • [23] Adjuvant trastuzumab for HER2-positive breast cancer
    Spicer, J
    Harries, M
    Ellis, P
    LANCET, 2005, 366 (9486): : 634 - 634
  • [24] Trastuzumab emtansine for HER2-positive breast cancer
    Venkatesan, Priya
    LANCET ONCOLOGY, 2016, 17 (12): : E528 - E528
  • [25] HER2-Positive Breast Cancer: Beyond Trastuzumab
    Murphy, Conleth G.
    Fornier, Monica
    ONCOLOGY-NEW YORK, 2010, 24 (05): : 410 - 415
  • [26] Combined lapatinib and paclitaxel in HER2-positive breast cancer
    Castaneda, Carlos A.
    Gomez, Henry L.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (06) : 308 - 309
  • [27] The emerging role of Lapatinib in HER2-positive breast cancer
    Alice Ulhoa-Cintra
    Larisa Greenberg
    Charles E. Geyer
    Current Oncology Reports, 2008, 10 : 10 - 17
  • [28] miRNAs in resistance to lapatinib in HER2-positive breast cancer
    Haley, V.
    Cavicchioli, F.
    Shia, A.
    O'Leary, K.
    Balakrishnan, L.
    Lo Nigro, C.
    Schmid, R.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S121 - S121
  • [29] The Emerging Role of Lapatinib in HER2-positive Breast Cancer
    Ulhoa-Cintra, Alice
    Greenberg, Larisa
    Geyer, Charles E.
    CURRENT ONCOLOGY REPORTS, 2008, 10 (01) : 10 - 17
  • [30] Pyrotinib versus lapatinib in HER2-positive breast cancer
    Gourd, Elizabeth
    LANCET ONCOLOGY, 2019, 20 (10): : E562 - E562
12345